ACO Name and Location Allina Health Minneapolis, Minnesota ACO Primary Contact Patrick Flesher Director, Payer Contracting & Pioneer ACO Program Email: Patrick.Flesher@allina.com Phone: 612-262-4865 Composition of ACO The Allina Health ACO is comprised of approximately 210 primary care providers located in Anoka, Brown, Hennepin and Ramsey counties. ACO Participants Allina Health Medicare Pioneer ACO providers ACO Governing Body Allina Health board of directors ACO Committees and Key Leadership Personnel Clinical Alignment & Performance Team Amount of Shared Savings/Losses Performance Year 1 (2012): None Performance Year 2 (2013): None ($1.9M in shared savings to Medicare) Performance Year 3 (2014): Results not available until mid-2015 How Shared Savings Are Distributed Reinvest in infrastructure: NA Distribution to ACO participants: NA o Primary Care Professionals: o o Specialists: Hospital:
Quality Performance Results - 2012 2012 Performance Summary Statistics Performance Measure ACO Performance Rate Mean Performance Rate for All ACOs Getting Timely Care, Appointments, and 83.47 80.96 Information (ACO-1) How Well Your Doctors Communicate (ACO-2) 93.15 92.64 Patients Rating of Doctor (ACO-3) 91.22 91.67 Access to Specialists (ACO-4) 83.16 84.66 Health Promotion and Education (ACO-5) 54.87 57.07 Shared Decision Making (ACO-6) 74.12 74.36 Health Status/Functional Status (ACO-7) 71.09 70.34 Risk Standardized, All Condition Readmissions 14.95 15.48 (ACO-8) ASC Admissions: COPD or Asthma in Older 1.05 1.07 Adults (ACO-9) ASC Admission: Heart Failure (ACO-10) 1.12 1.03 Percent of Primary Care Providers who 91.67 63.61 Qualified for EHR Incentive Payment (ACO-11) Medication Reconciliation (ACO-12) 13.23 70.55 Falls: Screening for Fall Risk (ACO-13) 62.10 35.64 Influenza Immunization (ACO-14) 68.04 53.37 Pneumococcal Vaccination (ACO-15) 92.72 57.26 Adult Weight Screening and Follow-up (ACO- 49.58 53.12 16) Tobacco Use Assessment and Cessation 94.50 77.82 Intervention (ACO-17) Depression Screening (ACO-18) 42.67 23.62 Colorectal Cancer Screening (ACO-19) 74.37 58.10 Mammography Screening (ACO-20) 73.65 64.77 Proportion of Adults who had blood pressure 41.32 63.16 screened in past 2 years (ACO-21) Beneficiaries with diabetes who met of all 52.46 25.52 the following criteria (composite score 22-26): Beneficiaries with diabetes who met of all the 82.81 64.73 following criteria: Hemoglobin A1c Control (HbA1c) (<8 percent) (ACO-22) Beneficiaries with diabetes who met of all the 74.91 55.12 following criteria: Low Density Lipoprotein (LDL) (< 100 mg/dl) (ACO-23) Beneficiaries with diabetes who met of all the 87.54 67.08 following criteria: Blood Pressure (BP) < 140/90 (ACO-24) Beneficiaries with diabetes who met of all the following criteria: Tobacco Non-Use (ACO-25) 85.79 66.61
Beneficiaries with diabetes who met of all the following criteria: Aspirin Use (ACO-26) 100 78.52 Percent of beneficiaries with diabetes whose 10.53 27.08 HbA1c in poor control (>9 percent) (ACO-27) Percent of beneficiaries with hypertension 75.82 63.94 whose BP < 140/90 (ACO-28) Percent of beneficiaries with IVD with complete 55.88 54.01 lipid profile and LDL control < 100mg/dl (ACO-29) Percent of beneficiaries who use Aspirin or 92.46 76.07 other antithrombotic (ACO-30) Beta-Blocker Therapy for LVSD (ACO-31) 97.92 82.05 Percent of beneficiaries with CAD who met 83.33 62.87 all of the following criteria (composite score 32, 33): Percent of beneficiaries with CAD who met all 87.06 69.43 of the following criteria: Drug Therapy for Lowering LDL-Cholesterol (ACO-32) Percent of beneficiaries with CAD who met all of the following criteria: (ACE) Inhibitor or (ARB) Therapy for Patients with CAD and Diabetes and/or (LVSD) (ACO-33) 86.84 71.12
Quality Performance Results - 2013 2013 Performance Summary Statistics Performance Measure ACO Performance Rate Mean Performance Rate for All ACOs Getting Timely Care, Appointments, and 85.61 81.48 Information (ACO-1) How Well Your Doctors Communicate (ACO-2) 94.06 92.96 Patients Rating of Doctor (ACO-3) 92.91 92.06 Access to Specialists (ACO-4) 84.15 85.12 Health Promotion and Education (ACO-5) 57.16 58.38 Shared Decision Making (ACO-6) 73.75 74..53 Health Status/Functional Status (ACO-7) 72.54 71.12 Risk Standardized, All Condition Readmissions 15.10 14.90 (ACO-8) ASC Admissions: COPD or Asthma in Older 1.13 1.17 Adults (ACO-9) ASC Admission: Heart Failure (ACO-10) 1.26 1.20 Percent of Primary Care Providers who 88.69% 66.21% Qualified for EHR Incentive Payment (ACO-11) Medication Reconciliation (ACO-12) 14.59% 70.05% Falls: Screening for Fall Risk (ACO-13) 56.41% 39.99% Influenza Immunization (ACO-14) 73.16% 57.28% Pneumococcal Vaccination (ACO-15) 93.36% 55.64% Adult Weight Screening and Follow-up (ACO- 46.50% 62.29% 16) Tobacco Use Assessment and Cessation 98.37% 84.77% Intervention (ACO-17) Depression Screening (ACO-18) 41.27% 31.81% Colorectal Cancer Screening (ACO-19) 80.07% 60.21% Mammography Screening (ACO-20) 79.30% 62.31% Proportion of Adults who had blood pressure 68.29% 74.55% screened in past 2 years (ACO-21) Beneficiaries with diabetes who met of all 51.07% 22.57% the following criteria (composite score 22-26): Beneficiaries with diabetes who met of all the 83.05% 68.87% following criteria: Hemoglobin A1c Control (HbA1c) (<8 percent) (ACO-22) Beneficiaries with diabetes who met of all the following criteria: Low Density Lipoprotein (LDL) (< 100 mg/dl) (ACO-23) 77.47% 55.23%
Beneficiaries with diabetes who met of all the 89.48% 70.23% following criteria: Blood Pressure (BP) < 140/90 (ACO-24) Beneficiaries with diabetes who met of all the 83.48% 70.23% following criteria: Tobacco Non-Use (ACO-25) Beneficiaries with diabetes who met of all the 100.00% 75.96% following criteria: Aspirin Use (ACO-26) Percent of beneficiaries with diabetes whose 9.87% 22.13% HbA1c in poor control (>9 percent) (ACO-27) Percent of beneficiaries with hypertension 83.48% 68.47% whose BP < 140/90 (ACO-28) Percent of beneficiaries with IVD with complete 66.61% 55.85% lipid profile and LDL control < 100mg/dl (ACO-29) Percent of beneficiaries who use Aspirin or 93.32% 77.27% other antithrombotic (ACO-30) Beta-Blocker Therapy for LVSD (ACO-31) 88.75% 80.79% Percent of beneficiaries with CAD who met 79.56% 63.63% all of the following criteria (composite score 32, 33): Percent of beneficiaries with CAD who met all 88.25% 72.26% of the following criteria: Drug Therapy for Lowering LDL-Cholesterol (ACO-32) Percent of beneficiaries with CAD who met all of the following criteria: (ACE) Inhibitor or (ARB) Therapy for Patients with CAD and Diabetes and/or (LVSD) (ACO-33) 75.21% 69.92%